Betulinic Acid Exerts Anti-Hepatitis C Virus Activity via the Suppression of NF-κB and MAPK-ERK1/2-Mediated COX-2 Expression
June 2015
in “
British Journal of Pharmacology
”
Studysummary This study found that betulinic acid inhibits hepatitis C virus replication by suppressing the NF-κB- and ERK1/2-mediated COX-2 pathway, suggesting its potential as a therapeutic supplement.
Automatically generated from the study's abstract, not written by a person, and not a review of the full paper. Not medical advice or a treatment recommendation. Read the original study, and consult a qualified healthcare professional before changing treatment. Full disclaimer
Read the full study on bpspubs.onlinelibrary.wiley.com →